Pure Collaborations

From the FDA to multi-national corporations, Pure is engineered for collaboration.

Cross-Reactive Antibody Screening Assay

Increasing the range of a proprietary platform.

Our partner is developing a cross-reactive antibody screening assay using Pure sHLA proteins incorporated into the partner’s proprietary detection chemistry platform. Initial feasibility studies are underway with a view toward product development to increase the range of applications addressable by their in-house platform technology.